Tech Company Financing Transactions

Auspex Pharmaceuticals Funding Round

Auspex Pharmaceuticals, operating out of La Jolla, secured $25 million from Panorama Capital, Presidio Partners and Sloan Biotech Fund.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

3366 North Torrey Pines Ct. 225
La Jolla, CA 92037
USA

Phone

(858) 558-2400

Website

www.auspexpharma.com

Email Address

[email protected]

Overview

Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pratik Shah

        

Chief Financial Officer

John Schmid

        

Chief Medical Officer

David Stamler

        

Chief Operating Officer

Bharatt Chowrira

        

Chief Operating Officer

Andreas Sommer

        

Browse more venture capital transactions:

Prev: 11/9/2012: Intronis Technologies venture capital transaction
Next: 11/9/2012: Knopp Biosciences venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary